✦ LIBER ✦

Comparison of the pharmacodynamic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trial

✍ Scribed by Cornelius F. Waller; Miguel Bronchud; Stuart Mair; Rodeina Challand

Book ID: 105989617
Publisher: Springer
Year: 2010
Tongue: English
Weight: 187 KB
Volume: 89
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-010-0973-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic profiles of a biosimilar

Pharmacokinetic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trial

✍ Cornelius F. Waller; Miguel Bronchud; Stuart Mair; Rodeina Challand 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 149 KB

The comparison of Filgrastim (Neupogen®)

The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: A single center experience from Turkey

✍ Sivgin, Serdar; Karakus, Esen; Kaynar, Leylagul; Kurnaz, Fatih; Pala, Cigdem; Ke 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 351 KB

A single dose of pegfilgrastim compared

A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial

✍ Jorge Sierra; Jeffrey Szer; Jeannine Kassis; Richard Herrmann; Mario Lazzarino; 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 307 KB

Pharmacokinetics of Lacosamide and Omepr

Pharmacokinetics of Lacosamide and Omeprazole Coadministration in Healthy Volunteers: Results from a Phase I, Randomized, Crossover Trial

✍ Cawello, Willi; Mueller-Voessing, Christa; Fichtner, Andreas 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 664 KB

Final Results of a Randomized Phase III

Final Results of a Randomized Phase III Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With a Dose-Intensified Epirubicin and Cyclophosphamide + Filgrastim as Neoadjuvant Treatment in Locally Advanced Breast Cancer: An EORTC-NCIC-SAKK Multicenter Study

✍ Therasse, P. 📂 Article 📅 2003 🏛 American Society of Clinical Oncology 🌐 English ⚖ 107 KB

Phase I trial of paclitaxel, carboplatin

Phase I trial of paclitaxel, carboplatin, and topotecan with or without filgrastim (granulocyte-colony stimulating factor) in the treatment of patients with advanced, refractory cancer

✍ John D. Hainsworth; Howard A. Burris III; Lisa H. Morrissey; F. Anthony Greco 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 3 views

## Background: Topotecan is a new antineoplastic agent with a broad spectrum of activity. the purpose of this phase i trial was to define the maximum tolerated dose of topotecan when added to the widely used combination of paclitaxel and carboplatin. ## Methods: Patients with advanced cancer that